Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects

NCT03262909 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Articular Cartilage Defects in the Knee Joint

Interventions

DEVICE: GelrinC
OTHER: Microfracture historical control arm

Sponsor

Regentis Biomaterials